SAIMSARA Journal

Machine Generated Science • ISSN 3054-3991

Peripheral Artery Disease Prevalence: Scoping Review with ☸️SAIMSARA.

Cardiac & Vascular Health icon

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

DOI: 10.62487/saimsaraec430229

Editorial note
• Last update: 2026-04-27 08:59:37
What is this paper about
This review shows that PAD is not a niche vascular diagnosis but a massive, underrecognized global burden that concentrates sharply in diabetes, kidney disease, stroke, and other high-risk populations while often remaining clinically silent. The full read is worth it because it maps where PAD prevalence is truly highest, why reported rates vary so widely, and which patient groups should trigger much earlier ABI-based case finding.
Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.


Abstract: The aim of this paper is to synthesize current evidence regarding the prevalence of PAD across diverse global populations, identify key independent risk factors, and evaluate the disease burden within specific high-risk clinical cohorts. The review utilises 198 references. The mapped evidence indicates that PAD is a common and growing manifestation of systemic atherosclerosis, with global cases exceeding 113 million by 2021 and prevalence in general adult populations typically ranging from about 1.23% to 13.7%. A consistent signal across topics was the marked concentration of burden in clinically enriched groups, where prevalence reached 41.9% in diabetes, 54% in hemodialysis, and 45.3% in abdominal aortic aneurysm cohorts. The review also highlights that a substantial proportion of disease is asymptomatic and that measured prevalence depends heavily on how PAD is defined and detected, supporting a practical role for targeted ABI-based case finding in high-risk settings rather than reliance on routine clinical recognition alone. At the same time, the wide spread of estimates across regions, comorbidity profiles, and diagnostic approaches suggests that the current evidence map is better interpreted as showing patterns of burden than as providing a single universal prevalence figure. Future research should prioritize standardized PAD ascertainment and harmonized reporting across general and high-risk populations so that prevalence comparisons become more clinically actionable and internationally comparable.

Keywords: Peripheral artery disease; Global prevalence; Type 2 diabetes mellitus; Cardiovascular comorbidities; Risk factors; Elderly population; Lower extremity arterial disease; Global burden of disease; Socioeconomic status; Mortality risk

Review Stats

Get access to the full paper

Unlock the full evidence map

The full evidence review, including the Introduction, Methods, Results, Discussion, Conclusion, figures, and complete reference index, opens after purchase or sign-in. The Evidence Object JSON is a separate machine-readable evidence product: a concentrated synthesis of results, topic-level evidence, and discussion across original and non-original studies. It can be directly input into your LLM, agent, or RAG workflow.

Reference Index (198)